Literature DB >> 12111307

Axial myopathy--an unrecognised entity.

Ibrahim Mahjneh1, G Marconi, A Paetau, A Saarinen, T Salmi, H Somer.   

Abstract

Axial myopathy (AM) is a rare neuromuscular disorder characterised by selective involvement of the spinal muscles with a bent spine and/or drooping head as leading clinical features. We here report the results of clinical, histopathological, MRI, molecular genetics and electrophysiological investigations carried out on six patients affected by pure axial myopathy. Symptoms appeared within an age range of 35 to 56 years. The first symptoms were difficulty in keeping the trunk and head in an upright position. Both bent spine and dropped head were reduced in a supine position. The disease was slowly progressive. Muscle strength examination and muscle imaging revealed involvement of the spinal and neck extensor muscles only. Serum CK was normal to slightly increased. EMG and muscle biopsy specimens obtained from spinal muscles showed an advanced chronic myopathic pattern. We conclude that axial myopathy may be much more common than previously thought, because gradual progression of cervical kyphosis may often be explained as a feature of normal ageing or as an associated sign of several neurological disorders and vertebral degeneration diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111307     DOI: 10.1007/s00415-002-0701-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

Review 1.  Disorders of paravertebral lumbar muscles: from pathology to cross-sectional imaging.

Authors:  Guillaume Bierry; Stéphane Kremer; Frauke Kellner; Maher Abu Eid; Adriana Bogorin; Jean-Louis Dietemann
Journal:  Skeletal Radiol       Date:  2008-05-08       Impact factor: 2.199

2.  IS DROPPED HEAD SYNDROME IN SPORADIC LATE-ONSET NEMALINE MYOPATHY ALWAYS UNTREATABLE?

Authors:  Simona Portaro; Rocco Salvatore Calabrò
Journal:  Innov Clin Neurosci       Date:  2020-04-01

3.  Rigid Spine Syndrome among Children in Oman.

Authors:  Roshan Koul; Dilip Sankhla; Suad Al-Jahdhami; Renjith Mani; Rana A Rahim; Saif Al-Yaarubi; Hussein Al-Kindy; Khalid Al-Thihli; Amna Al-Futaisi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-08-24

4.  Camptocormia phenotype of FSHD: a clinical and MRI study on six patients.

Authors:  Berit Jordan; Katharina Eger; Sabrina Koesling; Stephan Zierz
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

Review 5.  Camptocormia: the bent spine syndrome, an update.

Authors:  Thibaut Lenoir; Nathalie Guedj; Philippe Boulu; Pierre Guigui; Michel Benoist
Journal:  Eur Spine J       Date:  2010-03-19       Impact factor: 3.134

6.  Painful camptocormia: the relevance of shaking your patient's hand.

Authors:  Arnaud Dupeyron; Nina Stober; Anthony Gelis; Giovani Castelnovo; Pierre Labauge; Jacques Pélissier
Journal:  Eur Spine J       Date:  2009-07-10       Impact factor: 3.134

Review 7.  The utility of muscle biopsy.

Authors:  David Lacomis
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

8.  Whole-body muscle MRI to detect myopathies in non-extrapyramidal bent spine syndrome.

Authors:  Mickaël Ohana; Marie-Christine Durand; Catherine Marty; Jean-Philippe Lazareth; Thierry Maisonobe; Dominique Mompoint; Robert-Yves Carlier
Journal:  Skeletal Radiol       Date:  2014-05-31       Impact factor: 2.199

9.  Case Studies in Neuroscience: A dissociation of balance and posture demonstrated by camptocormia.

Authors:  R J St George; V S Gurfinkel; J Kraakevik; J G Nutt; F B Horak
Journal:  J Neurophysiol       Date:  2017-10-04       Impact factor: 2.714

10.  A new phenotype of mitochondrial disease characterized by familial late-onset predominant axial myopathy and encephalopathy.

Authors:  Yusuke Sakiyama; Yuji Okamoto; Itsuro Higuchi; Yukie Inamori; Yoko Sangatsuda; Kumiko Michizono; Osamu Watanabe; Hideyuki Hatakeyama; Yu-ichi Goto; Kimiyoshi Arimura; Hiroshi Takashima
Journal:  Acta Neuropathol       Date:  2011-03-22       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.